Kyowa Hakko Bio/Kirin Holdings will host a sponsored satellite
program at ASN's Annual Conference – NUTRITION 2024 to address how
citicoline can help prevent brain problems as we age.
NEW
YORK, June 29, 2024 /PRNewswire-PRWeb/ -- Kyowa
Hakko Bio Co., Ltd. and Kirin Holdings Company, Limited are
thrilled to announce their sponsored satellite program at the
American Society for Nutrition's (ASN) Annual Conference, NUTRITION
2024. This groundbreaking session will spotlight the
neuroprotective effects of citicoline, revealing its potential to
enhance cognitive function and combat brain aging.
Attendees will gain an in-depth understanding of how citicoline
works at a cellular level, positively impacting brain health. This
program will use advanced scientific techniques to examine its
effects on neurons, astrocytes, and microglia to explain the
significant benefits of citicoline supplementation. By the end of
this session, participants will:
- Understand how scientists use specialized tests to assess brain
health by examining brain cells.
- Learn about citicoline's potential cognitive and aging
benefits, supported by recent research.
- Discuss the necessity for further studies to fully comprehend
citicoline's role in maintaining brain health.
Participants will also access a comprehensive analysis
showcasing how citicoline can enhance cognitive function and
behavior, highlighting its potential as a supplement for combating
cognitive decline and promoting healthy brain aging.
Karen E. Todd, RD, CSCS, EP-C,
CISSN, and Vice President of Global Marketing of Kyowa Hakko
USA will be the chair of the
session that will feature two distinguished experts: Danielle Citrolo, PharmD, Vice President of
Scientific and Regulatory Affairs at Kyowa Hakko U.S.A., who will discuss "The Beneficial
Effects of Cognizin® Citicoline on Cognitive Function and
Behavior," and Loukia Lili, PhD,
Senior Director of Bioinformatics at Thorne HealthTech, and who
will lead a session on "Using Integrative Gene Expression and
Pathway Modeling Analysis to Characterize the Impacts of Citicoline
Administration on Brain Health."
Groundbreaking New Science
Understanding the scientific method behind the research is crucial.
A transcriptomic approach involves studying the activity of genes
in cells by examining all the RNA molecules produced by the genes
in a cell or group of cells. This method helps scientists
understand which genes are active, their utilization levels, and
how they change under different conditions. Such insights are vital
for learning how cells function and respond to various factors,
including treatments or diseases, potentially leading to healthier
cellular aging and longer, healthy lives.
Join us for this enlightening session on Saturday, June 29th, 2024, from 11:00 AM to 12:30 PM CST, room # W375B, and
discover how Cognizin® Citicoline can support brain health and
cognitive function!
For a deeper dive into science, join our poster theater session
featuring Eri Nakazaki, PhD, Manager
Kirin Holdings Company Limited. Investigating Specific Molecular
and Functional Impacts of Citicoline on Brain Health on
Sunday, June 30, 2024 at 12:00 PM CT in Hall F1 (The Hub).
For more information about ASN's Annual Conference – NUTRITION
2024, please visit https://nutrition.org/n24/
For more information about Cognizin®, please visit
https://cognizin.com/en.
Cognizin® Citicoline, manufactured by Kyowa Hakko Bio
Co., Ltd., is a clinically studied and branded form of Citicoline,
a natural substance made endogenously in the body and especially
vital to brain health. Citicoline is a potent brain-health
nutrient. A proprietary form of citicoline, Cognizin®
has been clinically studied to support mental energy, focus,
attention, and recall. Cognizin® is manufactured through
a fermentation process to yield high quality and high purity.
Cognizin® is also highly stable, GRAS, ultra-pure, and
allergen-free. For more information on Cognizin®, visit
Cognizin.com.
About Kyowa Hakko USA:
Kyowa Hakko USA is the North &
South American office of Kyowa Hakko Bio Co. Ltd., an international
health ingredients manufacturer and world leader in the
development, manufacturing, and marketing of pharmaceuticals,
nutraceuticals, and food & beverage products. Kyowa is the
maker of branded ingredients, including IMMUSE™ LC-Plasma, Eyemuse™
Lacticaseibacillus paracasei KW3110, Cognizin®
Citicoline, Pantesin® Pantethine, Setria®
Glutathione, as well as L-Alanyl-L-Glutamine. For more information,
visit http://www.kyowa-usa.com/.
About Kirin Holdings Company, Limited
Kirin Holdings Company, Limited is an international company that
operates in the Food & Beverages domain (Food & Beverages
businesses), Pharmaceuticals domain (Pharmaceuticals businesses),
and Health Science domain (Health Science business), both in
Japan and across the globe.
Media Contact:
Giselle Chollett
giselle@adinnyc.com
917.386.7116.
Media Contact
Maria Stanieich, Kyowa Hakko
USA, 5514829968,
stanieich@kyowa-usa.com, https://cognizin.com
View original content to download
multimedia:https://www.prweb.com/releases/unlocking-brain-health-the-power-of-cognizin-citicoline-revealed-302185833.html
SOURCE Kyowa Hakko USA